Wen-hui Wu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Amonafide Targeting NTSR1-PI3K/AKT/mTOR Signaling Attenuates Vascular Remodeling in Pulmonary Arterial Hypertension.
Journal: Journal of the American Heart Association
Published: May 14, 2026
Non-invasive PECS model for detection of combined post-capillary pulmonary hypertension.
Journal: Frontiers in medicine
Published: July 06, 2025
Right heart remodeling in end-stage pulmonary arterial hypertension and the impact of treatment intensity.
Journal: Frontiers in cardiovascular medicine
Published: June 09, 2025
sST2 and IL-6 predict prognosis of medically treated chronic thromboembolic pulmonary hypertension.
Journal: The European respiratory journal
Published: April 02, 2025
Episcleral vascular abnormalities in pulmonary arterial hypertension: clinical significance and genetic implications.
Journal: The European respiratory journal
Published: November 08, 2024
Hypoxanthine Promotes Pulmonary Vascular Remodeling and Adenosine Deaminase Is a Therapeutic Target for Pulmonary Hypertension.
Journal: JACC. Basic to translational science
Published: July 24, 2024
Thrombocytopenia in pediatrics: bridging the gap from discovery to management-a long way to go.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 17, 2024
Prognostic Value of Plasma Immunoglobulin G N-Glycome Traits in Pulmonary Arterial Hypertension.
Journal: Journal of the American College of Cardiology
Published: May 30, 2024
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
Journal: Circulation
Published: May 02, 2024
Sleep-disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary disease.
Journal: Internal medicine journal
Published: June 07, 2023
Last Updated: 09/26/2026